However, CDK2 and CDK4 were positively correlated with tumor purity in skin cutaneous melanomas, LUADs, LIHCs, head and neck cancers, glioblastomas, and breast invasive carcinoma. The gene discussed is CDK2; the disease is cutaneous melanoma.